Literature DB >> 21118906

Role of the NF-κB transcription factor c-Rel in the generation of CD8+ T-cell responses to Toxoplasma gondii.

Kimberly A Jordan1, Christopher D Dupont, Elia D Tait, Hsiou-Chi Liou, Christopher A Hunter.   

Abstract

The nuclear factor κB transcription factor c-Rel is exclusively expressed in immune cells and plays a role in numerous cellular functions including proliferation, survival and production of chemokines and cytokines. c-Rel has also been implicated in the regulation of multiple genes involved in innate and adaptive immune responses to the intracellular protozoan parasite Toxoplasma gondii, in particular IL-12. To better understand how this transcription factor controls the CD8(+) T-cell response to this organism, wild-type (WT) and c-Rel(-/-) mice were challenged with a replication-deficient strain of T. gondii that expresses the model antigen ovalbumin (OVA). These studies revealed that c-Rel was required for optimal primary expansion of OVA-specific CD8(+) T cells and that immunized c-Rel-deficient mice were susceptible to challenge with a virulent strain of T. gondii. However, when c-Rel(-/-) cells specific for OVA were adoptively transferred into a WT recipient, or c-Rel(-/-) mice were treated with IL-12 at the time of immunization, there was no apparent proliferative defect. Surprisingly, upon secondary challenge, antigen-specific CD8(+) T cells in c-Rel(-/-) mice expanded to a much greater degree in terms of frequency as well as numbers when compared with WT mice. Despite this, the cytokine responses of c-Rel(-/-) mice remained defective, consistent with their susceptibility to secondary challenge. Together, these results indicate that in this infection model, the major influence of c-Rel in generation of CD8(+) T-cell responses is through its regulation of the inflammatory environment, rather than playing a substantial T-cell-intrinsic role.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 21118906      PMCID: PMC2994544          DOI: 10.1093/intimm/dxq439

Source DB:  PubMed          Journal:  Int Immunol        ISSN: 0953-8178            Impact factor:   4.823


  68 in total

1.  c-Rel is crucial for lymphocyte proliferation but dispensable for T cell effector function.

Authors:  H C Liou; Z Jin; J Tumang; S Andjelic; K A Smith; M L Liou
Journal:  Int Immunol       Date:  1999-03       Impact factor: 4.823

2.  Effector and memory CD8+ T cell fate coupled by T-bet and eomesodermin.

Authors:  Andrew M Intlekofer; Naofumi Takemoto; E John Wherry; Sarah A Longworth; John T Northrup; Vikram R Palanivel; Alan C Mullen; Christopher R Gasink; Susan M Kaech; Joseph D Miller; Laurent Gapin; Kenneth Ryan; Andreas P Russ; Tullia Lindsten; Jordan S Orange; Ananda W Goldrath; Rafi Ahmed; Steven L Reiner
Journal:  Nat Immunol       Date:  2005-11-06       Impact factor: 25.606

3.  Type I IFNs provide a third signal to CD8 T cells to stimulate clonal expansion and differentiation.

Authors:  Julie M Curtsinger; Javier O Valenzuela; Pujya Agarwal; Debra Lins; Matthew F Mescher
Journal:  J Immunol       Date:  2005-04-15       Impact factor: 5.422

4.  Transient loss of MHC class I tetramer binding after CD8+ T cell activation reflects altered T cell effector function.

Authors:  Donald R Drake; Rebecca M Ream; Christopher W Lawrence; Thomas J Braciale
Journal:  J Immunol       Date:  2005-08-01       Impact factor: 5.422

5.  c-Rel is essential for B lymphocyte survival and cell cycle progression.

Authors:  J R Tumang; A Owyang; S Andjelic; Z Jin; R R Hardy; M L Liou; H C Liou
Journal:  Eur J Immunol       Date:  1998-12       Impact factor: 5.532

6.  Loss of CD8 and TCR binding to Class I MHC ligands following T cell activation.

Authors:  Charlly Kao; Mark A Daniels; Stephen C Jameson
Journal:  Int Immunol       Date:  2005-11-01       Impact factor: 4.823

7.  Mice lacking the transcription factor subunit Rel can clear an influenza infection and have functional anti-viral cytotoxic T cells but do not develop an optimal antibody response.

Authors:  L Harling-McNabb; G Deliyannis; D C Jackson; S Gerondakis; G Grigoriadis; L E Brown
Journal:  Int Immunol       Date:  1999-09       Impact factor: 4.823

8.  The NF-kappa B family member RelB is required for innate and adaptive immunity to Toxoplasma gondii.

Authors:  J Caamaño; J Alexander; L Craig; R Bravo; C A Hunter
Journal:  J Immunol       Date:  1999-10-15       Impact factor: 5.422

9.  Distinct roles for the NF-kappaB1 and c-Rel transcription factors in the differentiation and survival of plasmacytoid and conventional dendritic cells activated by TLR-9 signals.

Authors:  Meredith O'Keeffe; Raelene J Grumont; Hubertus Hochrein; Martina Fuchsberger; Raffi Gugasyan; David Vremec; Ken Shortman; Steve Gerondakis
Journal:  Blood       Date:  2005-07-21       Impact factor: 22.113

10.  Opposing roles of NF-kappaB family members in the regulation of NK cell proliferation and production of IFN-gamma.

Authors:  Cristina M Tato; Nicola Mason; David Artis; Sagi Shapira; Jorge C Caamano; Jay H Bream; Hsiou-Chi Liou; Christopher A Hunter
Journal:  Int Immunol       Date:  2006-02-15       Impact factor: 4.823

View more
  10 in total

Review 1.  Nucleic acid transfection and transgenesis in parasitic nematodes.

Authors:  James B Lok
Journal:  Parasitology       Date:  2011-08-31       Impact factor: 3.234

2.  The c-Rel Transcription Factor in Development and Disease.

Authors:  Thomas D Gilmore; Steve Gerondakis
Journal:  Genes Cancer       Date:  2011-07

3.  Caspase-8 promotes c-Rel-dependent inflammatory cytokine expression and resistance against Toxoplasma gondii.

Authors:  Alexandra A DeLaney; Corbett T Berry; David A Christian; Andrew Hart; Elisabet Bjanes; Meghan A Wynosky-Dolfi; Xinyuan Li; Bart Tummers; Irina A Udalova; Youhai H Chen; Uri Hershberg; Bruce D Freedman; Christopher A Hunter; Igor E Brodsky
Journal:  Proc Natl Acad Sci U S A       Date:  2019-05-30       Impact factor: 11.205

4.  Impact of secondary TCR engagement on the heterogeneity of pathogen-specific CD8+ T cell response during acute and chronic toxoplasmosis.

Authors:  Lindsey A Shallberg; Anthony T Phan; David A Christian; Joseph A Perry; Breanne E Haskins; Daniel P Beiting; Tajie H Harris; Anita A Koshy; Christopher A Hunter
Journal:  PLoS Pathog       Date:  2022-06-21       Impact factor: 7.464

Review 5.  Immune response and immunopathology during toxoplasmosis.

Authors:  Christopher D Dupont; David A Christian; Christopher A Hunter
Journal:  Semin Immunopathol       Date:  2012-09-07       Impact factor: 9.623

6.  c-Rel Is a Myeloid Checkpoint for Cancer Immunotherapy.

Authors:  Ting Li; Xinyuan Li; Ali Zamani; Wei Wang; Chin-Nien Lee; Mingyue Li; George Luo; Emily Eiler; Honghong Sun; Sankar Ghosh; Jian Jin; Ramachandran Murali; Qingguo Ruan; Weiyun Shi; Youhai H Chen
Journal:  Nat Cancer       Date:  2020-05-18

7.  Toxoplasma gondii superinfection and virulence during secondary infection correlate with the exact ROP5/ROP18 allelic combination.

Authors:  Kirk D C Jensen; Ana Camejo; Mariane B Melo; Cynthia Cordeiro; Lindsay Julien; Gijsbert M Grotenbreg; Eva-Maria Frickel; Hidde L Ploegh; Lucy Young; Jeroen P J Saeij
Journal:  mBio       Date:  2015-02-24       Impact factor: 7.867

8.  CNBP controls IL-12 gene transcription and Th1 immunity.

Authors:  Yongzhi Chen; Shruti Sharma; Patricia A Assis; Zhaozhao Jiang; Roland Elling; Andrew J Olive; Saiyu Hang; Jennifer Bernier; Jun R Huh; Christopher M Sassetti; David M Knipe; Ricardo T Gazzinelli; Katherine A Fitzgerald
Journal:  J Exp Med       Date:  2018-11-15       Impact factor: 14.307

Review 9.  Immune response against toxoplasmosis-some recent updates RH: Toxoplasma gondii immune response.

Authors:  Madiha Sana; Muhammad Rashid; Imran Rashid; Haroon Akbar; Jorge E Gomez-Marin; Isabelle Dimier-Poisson
Journal:  Int J Immunopathol Pharmacol       Date:  2022 Jan-Dec       Impact factor: 3.219

10.  Edwardsiella ictaluri T3SS Effector EseN Modulates Expression of Host Genes Involved in the Immune Response.

Authors:  Lidiya P Dubytska; Ranjan Koirala; Azhia Sanchez; Ronald Thune
Journal:  Microorganisms       Date:  2022-07-01
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.